nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—UGT1A1—Naltrexone—alcohol dependence	0.27	0.482	CbGbCtD
Erlotinib—CYP3A5—Disulfiram—alcohol dependence	0.0766	0.136	CbGbCtD
Erlotinib—ABCB1—Naltrexone—alcohol dependence	0.0536	0.0955	CbGbCtD
Erlotinib—CYP1A2—Citalopram—alcohol dependence	0.0406	0.0724	CbGbCtD
Erlotinib—ABCB1—Citalopram—alcohol dependence	0.0355	0.0633	CbGbCtD
Erlotinib—CYP2D6—Citalopram—alcohol dependence	0.0335	0.0596	CbGbCtD
Erlotinib—CYP3A4—Disulfiram—alcohol dependence	0.0299	0.0532	CbGbCtD
Erlotinib—CYP3A4—Citalopram—alcohol dependence	0.0213	0.0379	CbGbCtD
Erlotinib—Dermatitis acneiform—Disulfiram—alcohol dependence	0.0094	0.0511	CcSEcCtD
Erlotinib—Lung infection—Citalopram—alcohol dependence	0.00577	0.0314	CcSEcCtD
Erlotinib—ORM1—bile—alcohol dependence	0.0043	0.0318	CbGeAlD
Erlotinib—Tenderness—Disulfiram—alcohol dependence	0.00368	0.02	CcSEcCtD
Erlotinib—Neuropathy—Disulfiram—alcohol dependence	0.00301	0.0164	CcSEcCtD
Erlotinib—ORM1—saliva—alcohol dependence	0.0028	0.0207	CbGeAlD
Erlotinib—Dermatitis acneiform—Citalopram—alcohol dependence	0.00277	0.0151	CcSEcCtD
Erlotinib—Hepatic failure—Disulfiram—alcohol dependence	0.00259	0.0141	CcSEcCtD
Erlotinib—Deep vein thrombosis—Naltrexone—alcohol dependence	0.00246	0.0134	CcSEcCtD
Erlotinib—Haematochezia—Citalopram—alcohol dependence	0.00235	0.0128	CcSEcCtD
Erlotinib—Haematemesis—Acamprosate—alcohol dependence	0.00228	0.0124	CcSEcCtD
Erlotinib—Myopathy—Acamprosate—alcohol dependence	0.00225	0.0123	CcSEcCtD
Erlotinib—Rash pustular—Acamprosate—alcohol dependence	0.00198	0.0108	CcSEcCtD
Erlotinib—Hepatotoxicity—Naltrexone—alcohol dependence	0.00194	0.0105	CcSEcCtD
Erlotinib—Rigors—Naltrexone—alcohol dependence	0.00183	0.00997	CcSEcCtD
Erlotinib—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00176	0.00958	CcSEcCtD
Erlotinib—HIPK4—gonad—alcohol dependence	0.0017	0.0126	CbGeAlD
Erlotinib—Cellulitis—Naltrexone—alcohol dependence	0.00165	0.00895	CcSEcCtD
Erlotinib—Hepatitis—Disulfiram—alcohol dependence	0.00161	0.00877	CcSEcCtD
Erlotinib—Deep vein thrombosis—Citalopram—alcohol dependence	0.00156	0.00848	CcSEcCtD
Erlotinib—Melaena—Acamprosate—alcohol dependence	0.00154	0.00841	CcSEcCtD
Erlotinib—NR1I2—digestive system—alcohol dependence	0.00154	0.0114	CbGeAlD
Erlotinib—Colitis—Acamprosate—alcohol dependence	0.00152	0.00826	CcSEcCtD
Erlotinib—Folliculitis—Citalopram—alcohol dependence	0.00151	0.00821	CcSEcCtD
Erlotinib—Keratitis—Citalopram—alcohol dependence	0.00146	0.00795	CcSEcCtD
Erlotinib—AURKC—gonad—alcohol dependence	0.00145	0.0107	CbGeAlD
Erlotinib—Colitis—Naltrexone—alcohol dependence	0.00144	0.00782	CcSEcCtD
Erlotinib—Haematemesis—Citalopram—alcohol dependence	0.00136	0.00743	CcSEcCtD
Erlotinib—Myopathy—Citalopram—alcohol dependence	0.00135	0.00736	CcSEcCtD
Erlotinib—EPHA6—gonad—alcohol dependence	0.00134	0.00992	CbGeAlD
Erlotinib—HIPK4—endocrine gland—alcohol dependence	0.00128	0.00949	CbGeAlD
Erlotinib—NR1I2—endocrine gland—alcohol dependence	0.00127	0.00938	CbGeAlD
Erlotinib—Renal failure acute—Acamprosate—alcohol dependence	0.00124	0.00677	CcSEcCtD
Erlotinib—JAK3—digestive system—alcohol dependence	0.00123	0.00907	CbGeAlD
Erlotinib—HIPK4—testis—alcohol dependence	0.00122	0.00905	CbGeAlD
Erlotinib—LTK—testis—alcohol dependence	0.00121	0.00894	CbGeAlD
Erlotinib—Dermatitis bullous—Acamprosate—alcohol dependence	0.0012	0.00654	CcSEcCtD
Erlotinib—ULK3—forebrain—alcohol dependence	0.00119	0.0088	CbGeAlD
Erlotinib—Rash pustular—Citalopram—alcohol dependence	0.00119	0.00647	CcSEcCtD
Erlotinib—JAK3—blood—alcohol dependence	0.00117	0.00865	CbGeAlD
Erlotinib—FLT3—cardiovascular system—alcohol dependence	0.00117	0.00862	CbGeAlD
Erlotinib—Rigors—Citalopram—alcohol dependence	0.00116	0.00632	CcSEcCtD
Erlotinib—PIP4K2C—adrenal cortex—alcohol dependence	0.00115	0.00854	CbGeAlD
Erlotinib—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00115	0.00625	CcSEcCtD
Erlotinib—NR1I2—liver—alcohol dependence	0.00114	0.00846	CbGeAlD
Erlotinib—Acne—Citalopram—alcohol dependence	0.00113	0.00613	CcSEcCtD
Erlotinib—ULK3—adrenal cortex—alcohol dependence	0.0011	0.00815	CbGeAlD
Erlotinib—AURKC—endocrine gland—alcohol dependence	0.0011	0.0081	CbGeAlD
Erlotinib—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00109	0.00591	CcSEcCtD
Erlotinib—Cardiovascular disorder—Citalopram—alcohol dependence	0.00108	0.00587	CcSEcCtD
Erlotinib—TNK1—blood—alcohol dependence	0.00107	0.00794	CbGeAlD
Erlotinib—Rhabdomyolysis—Citalopram—alcohol dependence	0.00107	0.00583	CcSEcCtD
Erlotinib—FLT3—gonad—alcohol dependence	0.00106	0.00783	CbGeAlD
Erlotinib—Dry skin—Acamprosate—alcohol dependence	0.00105	0.00573	CcSEcCtD
Erlotinib—AURKC—testis—alcohol dependence	0.00104	0.00772	CbGeAlD
Erlotinib—Cellulitis—Citalopram—alcohol dependence	0.00104	0.00567	CcSEcCtD
Erlotinib—MKNK1—adrenal cortex—alcohol dependence	0.00104	0.00767	CbGeAlD
Erlotinib—AURKC—nervous system—alcohol dependence	0.00103	0.00758	CbGeAlD
Erlotinib—PIP4K2C—pancreas—alcohol dependence	0.00102	0.00757	CbGeAlD
Erlotinib—Drug interaction—Citalopram—alcohol dependence	0.00102	0.00556	CcSEcCtD
Erlotinib—Gastritis—Acamprosate—alcohol dependence	0.00102	0.00553	CcSEcCtD
Erlotinib—EPHA6—endocrine gland—alcohol dependence	0.00101	0.0075	CbGeAlD
Erlotinib—JAK3—endocrine gland—alcohol dependence	0.00101	0.0075	CbGeAlD
Erlotinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00101	0.00551	CcSEcCtD
Erlotinib—Dehydration—Naltrexone—alcohol dependence	0.00101	0.0055	CcSEcCtD
Erlotinib—Dysphagia—Acamprosate—alcohol dependence	0.000992	0.0054	CcSEcCtD
Erlotinib—Bone pain—Citalopram—alcohol dependence	0.000989	0.00539	CcSEcCtD
Erlotinib—Fatigue—Disulfiram—alcohol dependence	0.000987	0.00537	CcSEcCtD
Erlotinib—AURKC—central nervous system—alcohol dependence	0.000987	0.0073	CbGeAlD
Erlotinib—SLK—adrenal cortex—alcohol dependence	0.000983	0.00726	CbGeAlD
Erlotinib—Pain—Disulfiram—alcohol dependence	0.000979	0.00533	CcSEcCtD
Erlotinib—Pancreatitis—Acamprosate—alcohol dependence	0.000973	0.00529	CcSEcCtD
Erlotinib—JAK3—testis—alcohol dependence	0.000967	0.00715	CbGeAlD
Erlotinib—EPHA6—testis—alcohol dependence	0.000967	0.00715	CbGeAlD
Erlotinib—Musculoskeletal pain—Citalopram—alcohol dependence	0.000959	0.00522	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000958	0.00521	CcSEcCtD
Erlotinib—PIP4K2C—gonad—alcohol dependence	0.000956	0.00707	CbGeAlD
Erlotinib—JAK3—nervous system—alcohol dependence	0.00095	0.00702	CbGeAlD
Erlotinib—EPHA6—nervous system—alcohol dependence	0.00095	0.00702	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—alcohol dependence	0.000947	0.007	CbGeAlD
Erlotinib—TNK1—endocrine gland—alcohol dependence	0.000931	0.00688	CbGeAlD
Erlotinib—Melaena—Citalopram—alcohol dependence	0.000926	0.00504	CcSEcCtD
Erlotinib—FLT3—blood—alcohol dependence	0.000923	0.00682	CbGeAlD
Erlotinib—HIPK4—brain—alcohol dependence	0.000918	0.00679	CbGeAlD
Erlotinib—JAK3—central nervous system—alcohol dependence	0.000914	0.00676	CbGeAlD
Erlotinib—EPHA6—central nervous system—alcohol dependence	0.000914	0.00676	CbGeAlD
Erlotinib—ULK3—gonad—alcohol dependence	0.000913	0.00675	CbGeAlD
Erlotinib—Colitis—Citalopram—alcohol dependence	0.00091	0.00495	CcSEcCtD
Erlotinib—LTK—brain—alcohol dependence	0.000908	0.00671	CbGeAlD
Erlotinib—Weight decreased—Acamprosate—alcohol dependence	0.000897	0.00488	CcSEcCtD
Erlotinib—JAK3—cerebellum—alcohol dependence	0.000894	0.0066	CbGeAlD
Erlotinib—Neuropathy—Citalopram—alcohol dependence	0.00089	0.00484	CcSEcCtD
Erlotinib—Pneumonia—Acamprosate—alcohol dependence	0.00089	0.00484	CcSEcCtD
Erlotinib—TNK1—testis—alcohol dependence	0.000888	0.00657	CbGeAlD
Erlotinib—Depression—Acamprosate—alcohol dependence	0.000882	0.0048	CcSEcCtD
Erlotinib—ABL2—blood—alcohol dependence	0.000881	0.00651	CbGeAlD
Erlotinib—MAP3K19—testis—alcohol dependence	0.000879	0.0065	CbGeAlD
Erlotinib—Dry eye—Citalopram—alcohol dependence	0.000875	0.00477	CcSEcCtD
Erlotinib—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000872	0.00475	CcSEcCtD
Erlotinib—SLK—pancreas—alcohol dependence	0.000872	0.00644	CbGeAlD
Erlotinib—Myocardial infarction—Acamprosate—alcohol dependence	0.000867	0.00472	CcSEcCtD
Erlotinib—MAP3K19—nervous system—alcohol dependence	0.000863	0.00638	CbGeAlD
Erlotinib—Stomatitis—Acamprosate—alcohol dependence	0.000862	0.00469	CcSEcCtD
Erlotinib—MKNK1—gonad—alcohol dependence	0.00086	0.00635	CbGeAlD
Erlotinib—MAP2K5—brainstem—alcohol dependence	0.000853	0.00631	CbGeAlD
Erlotinib—Weight decreased—Naltrexone—alcohol dependence	0.000849	0.00462	CcSEcCtD
Erlotinib—Pneumonia—Naltrexone—alcohol dependence	0.000842	0.00458	CcSEcCtD
Erlotinib—TNK1—liver—alcohol dependence	0.00084	0.00621	CbGeAlD
Erlotinib—Infestation NOS—Naltrexone—alcohol dependence	0.000837	0.00455	CcSEcCtD
Erlotinib—Infestation—Naltrexone—alcohol dependence	0.000837	0.00455	CcSEcCtD
Erlotinib—ULK3—digestive system—alcohol dependence	0.000835	0.00617	CbGeAlD
Erlotinib—Depression—Naltrexone—alcohol dependence	0.000834	0.00454	CcSEcCtD
Erlotinib—Epistaxis—Acamprosate—alcohol dependence	0.000834	0.00454	CcSEcCtD
Erlotinib—PIP4K2C—blood—alcohol dependence	0.000833	0.00616	CbGeAlD
Erlotinib—MAP3K19—central nervous system—alcohol dependence	0.000831	0.00614	CbGeAlD
Erlotinib—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000825	0.00449	CcSEcCtD
Erlotinib—PIP4K2C—midbrain—alcohol dependence	0.000823	0.00608	CbGeAlD
Erlotinib—Sepsis—Citalopram—alcohol dependence	0.000823	0.00448	CcSEcCtD
Erlotinib—Asthenia—Disulfiram—alcohol dependence	0.000822	0.00447	CcSEcCtD
Erlotinib—TNK1—cerebellum—alcohol dependence	0.00082	0.00606	CbGeAlD
Erlotinib—Myocardial infarction—Naltrexone—alcohol dependence	0.00082	0.00446	CcSEcCtD
Erlotinib—Conjunctivitis—Naltrexone—alcohol dependence	0.000813	0.00443	CcSEcCtD
Erlotinib—FLT3—endocrine gland—alcohol dependence	0.0008	0.00591	CbGeAlD
Erlotinib—Haemoglobin—Acamprosate—alcohol dependence	0.000798	0.00434	CcSEcCtD
Erlotinib—ULK3—blood—alcohol dependence	0.000796	0.00588	CbGeAlD
Erlotinib—Haemorrhage—Acamprosate—alcohol dependence	0.000794	0.00432	CcSEcCtD
Erlotinib—Hepatitis—Acamprosate—alcohol dependence	0.000794	0.00432	CcSEcCtD
Erlotinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000791	0.00431	CcSEcCtD
Erlotinib—Epistaxis—Naltrexone—alcohol dependence	0.000789	0.0043	CcSEcCtD
Erlotinib—MKNK1—digestive system—alcohol dependence	0.000786	0.00581	CbGeAlD
Erlotinib—ULK3—midbrain—alcohol dependence	0.000786	0.00581	CbGeAlD
Erlotinib—AURKC—brain—alcohol dependence	0.000784	0.00579	CbGeAlD
Erlotinib—STK10—cardiovascular system—alcohol dependence	0.00078	0.00576	CbGeAlD
Erlotinib—Hepatic failure—Citalopram—alcohol dependence	0.000766	0.00417	CcSEcCtD
Erlotinib—MAP2K5—adrenal cortex—alcohol dependence	0.000763	0.00564	CbGeAlD
Erlotinib—FLT3—testis—alcohol dependence	0.000763	0.00564	CbGeAlD
Erlotinib—Haemolytic anaemia—Citalopram—alcohol dependence	0.000762	0.00415	CcSEcCtD
Erlotinib—Dizziness—Disulfiram—alcohol dependence	0.000757	0.00412	CcSEcCtD
Erlotinib—Hepatitis—Naltrexone—alcohol dependence	0.000751	0.00409	CcSEcCtD
Erlotinib—MKNK1—blood—alcohol dependence	0.000749	0.00554	CbGeAlD
Erlotinib—Renal failure acute—Citalopram—alcohol dependence	0.000745	0.00406	CcSEcCtD
Erlotinib—MKNK1—midbrain—alcohol dependence	0.00074	0.00547	CbGeAlD
Erlotinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.000738	0.00402	CcSEcCtD
Erlotinib—ABL2—testis—alcohol dependence	0.000729	0.00539	CbGeAlD
Erlotinib—JAK3—brain—alcohol dependence	0.000726	0.00536	CbGeAlD
Erlotinib—EPHA6—brain—alcohol dependence	0.000726	0.00536	CbGeAlD
Erlotinib—PIP4K2C—endocrine gland—alcohol dependence	0.000723	0.00534	CbGeAlD
Erlotinib—Rash—Disulfiram—alcohol dependence	0.000722	0.00393	CcSEcCtD
Erlotinib—FLT3—liver—alcohol dependence	0.000721	0.00533	CbGeAlD
Erlotinib—Dermatitis bullous—Citalopram—alcohol dependence	0.00072	0.00392	CcSEcCtD
Erlotinib—Headache—Disulfiram—alcohol dependence	0.000717	0.0039	CcSEcCtD
Erlotinib—Chills—Acamprosate—alcohol dependence	0.000712	0.00388	CcSEcCtD
Erlotinib—EGFR—testis—alcohol dependence	0.000711	0.00526	CbGeAlD
Erlotinib—SLK—blood—alcohol dependence	0.000709	0.00524	CbGeAlD
Erlotinib—STK10—gonad—alcohol dependence	0.000708	0.00523	CbGeAlD
Erlotinib—FLT3—cerebellum—alcohol dependence	0.000705	0.00521	CbGeAlD
Erlotinib—Cerebrovascular accident—Citalopram—alcohol dependence	0.000702	0.00382	CcSEcCtD
Erlotinib—Eye disorder—Naltrexone—alcohol dependence	0.000702	0.00382	CcSEcCtD
Erlotinib—Alopecia—Acamprosate—alcohol dependence	0.000702	0.00382	CcSEcCtD
Erlotinib—SLK—midbrain—alcohol dependence	0.0007	0.00518	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—alcohol dependence	0.000696	0.00515	CbGeAlD
Erlotinib—Mental disorder—Acamprosate—alcohol dependence	0.000696	0.00379	CcSEcCtD
Erlotinib—Malnutrition—Acamprosate—alcohol dependence	0.000691	0.00376	CcSEcCtD
Erlotinib—ULK3—endocrine gland—alcohol dependence	0.00069	0.0051	CbGeAlD
Erlotinib—PIP4K2C—testis—alcohol dependence	0.000689	0.0051	CbGeAlD
Erlotinib—ABL2—liver—alcohol dependence	0.000689	0.00509	CbGeAlD
Erlotinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000688	0.00375	CcSEcCtD
Erlotinib—Flatulence—Acamprosate—alcohol dependence	0.000681	0.00371	CcSEcCtD
Erlotinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000677	0.00369	CcSEcCtD
Erlotinib—PIP4K2C—nervous system—alcohol dependence	0.000677	0.005	CbGeAlD
Erlotinib—Chills—Naltrexone—alcohol dependence	0.000674	0.00367	CcSEcCtD
Erlotinib—ABL2—cerebellum—alcohol dependence	0.000673	0.00497	CbGeAlD
Erlotinib—EGFR—liver—alcohol dependence	0.000672	0.00497	CbGeAlD
Erlotinib—Back pain—Acamprosate—alcohol dependence	0.000669	0.00364	CcSEcCtD
Erlotinib—TNK1—brain—alcohol dependence	0.000666	0.00493	CbGeAlD
Erlotinib—Alopecia—Naltrexone—alcohol dependence	0.000664	0.00361	CcSEcCtD
Erlotinib—MAP3K19—brain—alcohol dependence	0.00066	0.00488	CbGeAlD
Erlotinib—ABL1—brainstem—alcohol dependence	0.000658	0.00487	CbGeAlD
Erlotinib—ULK3—testis—alcohol dependence	0.000658	0.00487	CbGeAlD
Erlotinib—Mental disorder—Naltrexone—alcohol dependence	0.000658	0.00358	CcSEcCtD
Erlotinib—EGFR—cerebellum—alcohol dependence	0.000657	0.00485	CbGeAlD
Erlotinib—Malnutrition—Naltrexone—alcohol dependence	0.000654	0.00356	CcSEcCtD
Erlotinib—PIP4K2C—liver—alcohol dependence	0.000652	0.00482	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—alcohol dependence	0.000651	0.00481	CbGeAlD
Erlotinib—MKNK1—endocrine gland—alcohol dependence	0.00065	0.0048	CbGeAlD
Erlotinib—STK10—digestive system—alcohol dependence	0.000647	0.00479	CbGeAlD
Erlotinib—ULK3—nervous system—alcohol dependence	0.000646	0.00477	CbGeAlD
Erlotinib—Flatulence—Naltrexone—alcohol dependence	0.000644	0.00351	CcSEcCtD
Erlotinib—SLCO2B1—forebrain—alcohol dependence	0.000641	0.00474	CbGeAlD
Erlotinib—Dehydration—Citalopram—alcohol dependence	0.00064	0.00348	CcSEcCtD
Erlotinib—PIP4K2C—cerebellum—alcohol dependence	0.000637	0.00471	CbGeAlD
Erlotinib—Back pain—Naltrexone—alcohol dependence	0.000633	0.00344	CcSEcCtD
Erlotinib—Dry skin—Citalopram—alcohol dependence	0.000631	0.00343	CcSEcCtD
Erlotinib—Hypokalaemia—Citalopram—alcohol dependence	0.000626	0.00341	CcSEcCtD
Erlotinib—ULK3—liver—alcohol dependence	0.000622	0.0046	CbGeAlD
Erlotinib—ULK3—central nervous system—alcohol dependence	0.000622	0.0046	CbGeAlD
Erlotinib—Syncope—Acamprosate—alcohol dependence	0.00062	0.00337	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00062	0.00337	CcSEcCtD
Erlotinib—MKNK1—testis—alcohol dependence	0.00062	0.00458	CbGeAlD
Erlotinib—STK10—blood—alcohol dependence	0.000617	0.00456	CbGeAlD
Erlotinib—UGT1A1—digestive system—alcohol dependence	0.000611	0.00452	CbGeAlD
Erlotinib—Gastritis—Citalopram—alcohol dependence	0.000609	0.00331	CcSEcCtD
Erlotinib—MKNK1—nervous system—alcohol dependence	0.000608	0.00449	CbGeAlD
Erlotinib—ULK3—cerebellum—alcohol dependence	0.000608	0.00449	CbGeAlD
Erlotinib—Loss of consciousness—Acamprosate—alcohol dependence	0.000607	0.00331	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000607	0.0033	CcSEcCtD
Erlotinib—Cough—Acamprosate—alcohol dependence	0.000603	0.00328	CcSEcCtD
Erlotinib—Dysphagia—Citalopram—alcohol dependence	0.000595	0.00324	CcSEcCtD
Erlotinib—ABL1—adrenal cortex—alcohol dependence	0.000589	0.00435	CbGeAlD
Erlotinib—Chest pain—Acamprosate—alcohol dependence	0.000588	0.0032	CcSEcCtD
Erlotinib—Arthralgia—Acamprosate—alcohol dependence	0.000588	0.0032	CcSEcCtD
Erlotinib—Myalgia—Acamprosate—alcohol dependence	0.000588	0.0032	CcSEcCtD
Erlotinib—SLK—testis—alcohol dependence	0.000587	0.00434	CbGeAlD
Erlotinib—Syncope—Naltrexone—alcohol dependence	0.000586	0.00319	CcSEcCtD
Erlotinib—Anxiety—Acamprosate—alcohol dependence	0.000586	0.00319	CcSEcCtD
Erlotinib—MKNK1—liver—alcohol dependence	0.000586	0.00433	CbGeAlD
Erlotinib—MKNK1—central nervous system—alcohol dependence	0.000585	0.00433	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000584	0.00318	CcSEcCtD
Erlotinib—Pancreatitis—Citalopram—alcohol dependence	0.000583	0.00317	CcSEcCtD
Erlotinib—UGT1A1—blood—alcohol dependence	0.000582	0.00431	CbGeAlD
Erlotinib—Loss of consciousness—Naltrexone—alcohol dependence	0.000575	0.00313	CcSEcCtD
Erlotinib—MKNK1—cerebellum—alcohol dependence	0.000572	0.00423	CbGeAlD
Erlotinib—Cough—Naltrexone—alcohol dependence	0.000571	0.00311	CcSEcCtD
Erlotinib—Infection—Acamprosate—alcohol dependence	0.00056	0.00305	CcSEcCtD
Erlotinib—Arthralgia—Naltrexone—alcohol dependence	0.000557	0.00303	CcSEcCtD
Erlotinib—Chest pain—Naltrexone—alcohol dependence	0.000557	0.00303	CcSEcCtD
Erlotinib—Myalgia—Naltrexone—alcohol dependence	0.000557	0.00303	CcSEcCtD
Erlotinib—Shock—Acamprosate—alcohol dependence	0.000555	0.00302	CcSEcCtD
Erlotinib—Anxiety—Naltrexone—alcohol dependence	0.000555	0.00302	CcSEcCtD
Erlotinib—SLK—liver—alcohol dependence	0.000555	0.0041	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000553	0.00301	CcSEcCtD
Erlotinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000552	0.00301	CcSEcCtD
Erlotinib—MAP2K5—blood—alcohol dependence	0.000551	0.00407	CbGeAlD
Erlotinib—Skin disorder—Acamprosate—alcohol dependence	0.000548	0.00298	CcSEcCtD
Erlotinib—ABL2—brain—alcohol dependence	0.000547	0.00404	CbGeAlD
Erlotinib—MAP2K5—midbrain—alcohol dependence	0.000544	0.00402	CbGeAlD
Erlotinib—SLK—cerebellum—alcohol dependence	0.000542	0.004	CbGeAlD
Erlotinib—Weight decreased—Citalopram—alcohol dependence	0.000538	0.00293	CcSEcCtD
Erlotinib—Anorexia—Acamprosate—alcohol dependence	0.000538	0.00293	CcSEcCtD
Erlotinib—ABL1—cardiovascular system—alcohol dependence	0.000537	0.00397	CbGeAlD
Erlotinib—STK10—endocrine gland—alcohol dependence	0.000535	0.00395	CbGeAlD
Erlotinib—Oedema—Naltrexone—alcohol dependence	0.000534	0.00291	CcSEcCtD
Erlotinib—EGFR—brain—alcohol dependence	0.000533	0.00394	CbGeAlD
Erlotinib—Pneumonia—Citalopram—alcohol dependence	0.000533	0.0029	CcSEcCtD
Erlotinib—Infection—Naltrexone—alcohol dependence	0.00053	0.00289	CcSEcCtD
Erlotinib—Infestation NOS—Citalopram—alcohol dependence	0.00053	0.00289	CcSEcCtD
Erlotinib—Infestation—Citalopram—alcohol dependence	0.00053	0.00289	CcSEcCtD
Erlotinib—Depression—Citalopram—alcohol dependence	0.000529	0.00288	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000526	0.00286	CcSEcCtD
Erlotinib—Shock—Naltrexone—alcohol dependence	0.000525	0.00286	CcSEcCtD
Erlotinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000523	0.00285	CcSEcCtD
Erlotinib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000523	0.00285	CcSEcCtD
Erlotinib—ABL1—pancreas—alcohol dependence	0.000522	0.00386	CbGeAlD
Erlotinib—Myocardial infarction—Citalopram—alcohol dependence	0.00052	0.00283	CcSEcCtD
Erlotinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.00052	0.00283	CcSEcCtD
Erlotinib—Skin disorder—Naltrexone—alcohol dependence	0.000518	0.00282	CcSEcCtD
Erlotinib—PIP4K2C—brain—alcohol dependence	0.000517	0.00382	CbGeAlD
Erlotinib—Stomatitis—Citalopram—alcohol dependence	0.000517	0.00281	CcSEcCtD
Erlotinib—Conjunctivitis—Citalopram—alcohol dependence	0.000515	0.00281	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000514	0.0028	CcSEcCtD
Erlotinib—Insomnia—Acamprosate—alcohol dependence	0.00051	0.00278	CcSEcCtD
Erlotinib—STK10—testis—alcohol dependence	0.00051	0.00377	CbGeAlD
Erlotinib—Anorexia—Naltrexone—alcohol dependence	0.000509	0.00277	CcSEcCtD
Erlotinib—UGT1A1—endocrine gland—alcohol dependence	0.000505	0.00373	CbGeAlD
Erlotinib—Dyspnoea—Acamprosate—alcohol dependence	0.000503	0.00274	CcSEcCtD
Erlotinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000501	0.00273	CcSEcCtD
Erlotinib—STK10—nervous system—alcohol dependence	0.000501	0.0037	CbGeAlD
Erlotinib—Epistaxis—Citalopram—alcohol dependence	0.0005	0.00272	CcSEcCtD
Erlotinib—Dyspepsia—Acamprosate—alcohol dependence	0.000497	0.0027	CcSEcCtD
Erlotinib—ULK3—brain—alcohol dependence	0.000494	0.00365	CbGeAlD
Erlotinib—Decreased appetite—Acamprosate—alcohol dependence	0.00049	0.00267	CcSEcCtD
Erlotinib—ABL1—gonad—alcohol dependence	0.000488	0.0036	CbGeAlD
Erlotinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000487	0.00265	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000486	0.00265	CcSEcCtD
Erlotinib—Insomnia—Naltrexone—alcohol dependence	0.000483	0.00263	CcSEcCtD
Erlotinib—Pain—Acamprosate—alcohol dependence	0.000482	0.00263	CcSEcCtD
Erlotinib—Constipation—Acamprosate—alcohol dependence	0.000482	0.00263	CcSEcCtD
Erlotinib—STK10—liver—alcohol dependence	0.000482	0.00356	CbGeAlD
Erlotinib—STK10—central nervous system—alcohol dependence	0.000482	0.00356	CbGeAlD
Erlotinib—Haemoglobin—Citalopram—alcohol dependence	0.000478	0.0026	CcSEcCtD
Erlotinib—MAP2K5—endocrine gland—alcohol dependence	0.000478	0.00353	CbGeAlD
Erlotinib—Hepatitis—Citalopram—alcohol dependence	0.000476	0.00259	CcSEcCtD
Erlotinib—Haemorrhage—Citalopram—alcohol dependence	0.000476	0.00259	CcSEcCtD
Erlotinib—Dyspnoea—Naltrexone—alcohol dependence	0.000476	0.00259	CcSEcCtD
Erlotinib—STK10—cerebellum—alcohol dependence	0.000471	0.00348	CbGeAlD
Erlotinib—Urinary tract disorder—Citalopram—alcohol dependence	0.00047	0.00256	CcSEcCtD
Erlotinib—Connective tissue disorder—Citalopram—alcohol dependence	0.000468	0.00255	CcSEcCtD
Erlotinib—Urethral disorder—Citalopram—alcohol dependence	0.000467	0.00254	CcSEcCtD
Erlotinib—MKNK1—brain—alcohol dependence	0.000465	0.00344	CbGeAlD
Erlotinib—Decreased appetite—Naltrexone—alcohol dependence	0.000464	0.00253	CcSEcCtD
Erlotinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000461	0.00251	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000461	0.00251	CcSEcCtD
Erlotinib—Fatigue—Naltrexone—alcohol dependence	0.00046	0.0025	CcSEcCtD
Erlotinib—Constipation—Naltrexone—alcohol dependence	0.000456	0.00248	CcSEcCtD
Erlotinib—Pain—Naltrexone—alcohol dependence	0.000456	0.00248	CcSEcCtD
Erlotinib—MAP2K5—testis—alcohol dependence	0.000456	0.00337	CbGeAlD
Erlotinib—UGT1A1—liver—alcohol dependence	0.000455	0.00337	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—alcohol dependence	0.000455	0.00336	CbGeAlD
Erlotinib—Erythema multiforme—Citalopram—alcohol dependence	0.00045	0.00245	CcSEcCtD
Erlotinib—SLCO2B1—digestive system—alcohol dependence	0.00045	0.00333	CbGeAlD
Erlotinib—ORM1—blood—alcohol dependence	0.000447	0.00331	CbGeAlD
Erlotinib—MAP2K5—nervous system—alcohol dependence	0.000447	0.0033	CbGeAlD
Erlotinib—ABL1—digestive system—alcohol dependence	0.000446	0.0033	CbGeAlD
Erlotinib—Abdominal pain—Acamprosate—alcohol dependence	0.000446	0.00243	CcSEcCtD
Erlotinib—Body temperature increased—Acamprosate—alcohol dependence	0.000446	0.00243	CcSEcCtD
Erlotinib—Eye disorder—Citalopram—alcohol dependence	0.000445	0.00242	CcSEcCtD
Erlotinib—SLK—brain—alcohol dependence	0.00044	0.00325	CbGeAlD
Erlotinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000436	0.00238	CcSEcCtD
Erlotinib—MAP2K5—liver—alcohol dependence	0.000431	0.00318	CbGeAlD
Erlotinib—MAP2K5—central nervous system—alcohol dependence	0.00043	0.00318	CbGeAlD
Erlotinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000429	0.00233	CcSEcCtD
Erlotinib—Chills—Citalopram—alcohol dependence	0.000427	0.00232	CcSEcCtD
Erlotinib—Arrhythmia—Citalopram—alcohol dependence	0.000425	0.00231	CcSEcCtD
Erlotinib—ABL1—blood—alcohol dependence	0.000425	0.00314	CbGeAlD
Erlotinib—Abdominal pain—Naltrexone—alcohol dependence	0.000422	0.0023	CcSEcCtD
Erlotinib—Body temperature increased—Naltrexone—alcohol dependence	0.000422	0.0023	CcSEcCtD
Erlotinib—MAP2K5—cerebellum—alcohol dependence	0.000421	0.00311	CbGeAlD
Erlotinib—Alopecia—Citalopram—alcohol dependence	0.000421	0.00229	CcSEcCtD
Erlotinib—ABL1—midbrain—alcohol dependence	0.00042	0.0031	CbGeAlD
Erlotinib—Mental disorder—Citalopram—alcohol dependence	0.000417	0.00227	CcSEcCtD
Erlotinib—Erythema—Citalopram—alcohol dependence	0.000414	0.00226	CcSEcCtD
Erlotinib—Malnutrition—Citalopram—alcohol dependence	0.000414	0.00226	CcSEcCtD
Erlotinib—CYP1B1—gonad—alcohol dependence	0.000413	0.00305	CbGeAlD
Erlotinib—Flatulence—Citalopram—alcohol dependence	0.000408	0.00222	CcSEcCtD
Erlotinib—Asthenia—Acamprosate—alcohol dependence	0.000405	0.0022	CcSEcCtD
Erlotinib—Back pain—Citalopram—alcohol dependence	0.000401	0.00218	CcSEcCtD
Erlotinib—Pruritus—Acamprosate—alcohol dependence	0.000399	0.00217	CcSEcCtD
Erlotinib—ORM1—endocrine gland—alcohol dependence	0.000388	0.00287	CbGeAlD
Erlotinib—Diarrhoea—Acamprosate—alcohol dependence	0.000386	0.0021	CcSEcCtD
Erlotinib—Asthenia—Naltrexone—alcohol dependence	0.000383	0.00208	CcSEcCtD
Erlotinib—STK10—brain—alcohol dependence	0.000383	0.00283	CbGeAlD
Erlotinib—CYP1B1—digestive system—alcohol dependence	0.000378	0.00279	CbGeAlD
Erlotinib—Pruritus—Naltrexone—alcohol dependence	0.000378	0.00206	CcSEcCtD
Erlotinib—Dizziness—Acamprosate—alcohol dependence	0.000373	0.00203	CcSEcCtD
Erlotinib—SLCO2B1—endocrine gland—alcohol dependence	0.000372	0.00275	CbGeAlD
Erlotinib—Syncope—Citalopram—alcohol dependence	0.000372	0.00202	CcSEcCtD
Erlotinib—ABCG2—adrenal cortex—alcohol dependence	0.000371	0.00274	CbGeAlD
Erlotinib—ABL1—endocrine gland—alcohol dependence	0.000369	0.00272	CbGeAlD
Erlotinib—Diarrhoea—Naltrexone—alcohol dependence	0.000365	0.00199	CcSEcCtD
Erlotinib—Loss of consciousness—Citalopram—alcohol dependence	0.000364	0.00198	CcSEcCtD
Erlotinib—ORM1—nervous system—alcohol dependence	0.000363	0.00268	CbGeAlD
Erlotinib—Cough—Citalopram—alcohol dependence	0.000362	0.00197	CcSEcCtD
Erlotinib—CYP1B1—blood—alcohol dependence	0.00036	0.00266	CbGeAlD
Erlotinib—Vomiting—Acamprosate—alcohol dependence	0.000359	0.00195	CcSEcCtD
Erlotinib—Rash—Acamprosate—alcohol dependence	0.000356	0.00194	CcSEcCtD
Erlotinib—Dermatitis—Acamprosate—alcohol dependence	0.000355	0.00193	CcSEcCtD
Erlotinib—SLCO2B1—testis—alcohol dependence	0.000355	0.00262	CbGeAlD
Erlotinib—Headache—Acamprosate—alcohol dependence	0.000353	0.00192	CcSEcCtD
Erlotinib—Dizziness—Naltrexone—alcohol dependence	0.000353	0.00192	CcSEcCtD
Erlotinib—Myalgia—Citalopram—alcohol dependence	0.000353	0.00192	CcSEcCtD
Erlotinib—Chest pain—Citalopram—alcohol dependence	0.000353	0.00192	CcSEcCtD
Erlotinib—Arthralgia—Citalopram—alcohol dependence	0.000353	0.00192	CcSEcCtD
Erlotinib—Anxiety—Citalopram—alcohol dependence	0.000352	0.00191	CcSEcCtD
Erlotinib—ABL1—testis—alcohol dependence	0.000351	0.0026	CbGeAlD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00035	0.00191	CcSEcCtD
Erlotinib—ORM1—liver—alcohol dependence	0.00035	0.00258	CbGeAlD
Erlotinib—ORM1—central nervous system—alcohol dependence	0.00035	0.00258	CbGeAlD
Erlotinib—SLCO2B1—nervous system—alcohol dependence	0.000348	0.00257	CbGeAlD
Erlotinib—ABL1—nervous system—alcohol dependence	0.000345	0.00255	CbGeAlD
Erlotinib—MAP2K5—brain—alcohol dependence	0.000342	0.00253	CbGeAlD
Erlotinib—Vomiting—Naltrexone—alcohol dependence	0.000339	0.00185	CcSEcCtD
Erlotinib—Oedema—Citalopram—alcohol dependence	0.000338	0.00184	CcSEcCtD
Erlotinib—Rash—Naltrexone—alcohol dependence	0.000337	0.00183	CcSEcCtD
Erlotinib—Dermatitis—Naltrexone—alcohol dependence	0.000336	0.00183	CcSEcCtD
Erlotinib—Infection—Citalopram—alcohol dependence	0.000336	0.00183	CcSEcCtD
Erlotinib—SLCO2B1—liver—alcohol dependence	0.000335	0.00248	CbGeAlD
Erlotinib—Nausea—Acamprosate—alcohol dependence	0.000335	0.00182	CcSEcCtD
Erlotinib—SLCO2B1—central nervous system—alcohol dependence	0.000335	0.00248	CbGeAlD
Erlotinib—Headache—Naltrexone—alcohol dependence	0.000334	0.00182	CcSEcCtD
Erlotinib—Shock—Citalopram—alcohol dependence	0.000333	0.00181	CcSEcCtD
Erlotinib—ABL1—liver—alcohol dependence	0.000332	0.00246	CbGeAlD
Erlotinib—ABL1—central nervous system—alcohol dependence	0.000332	0.00245	CbGeAlD
Erlotinib—Nervous system disorder—Citalopram—alcohol dependence	0.000332	0.00181	CcSEcCtD
Erlotinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000331	0.0018	CcSEcCtD
Erlotinib—Skin disorder—Citalopram—alcohol dependence	0.000328	0.00179	CcSEcCtD
Erlotinib—SLCO2B1—cerebellum—alcohol dependence	0.000327	0.00242	CbGeAlD
Erlotinib—ABL1—cerebellum—alcohol dependence	0.000325	0.0024	CbGeAlD
Erlotinib—ALB—testis—alcohol dependence	0.000324	0.0024	CbGeAlD
Erlotinib—Anorexia—Citalopram—alcohol dependence	0.000322	0.00175	CcSEcCtD
Erlotinib—Nausea—Naltrexone—alcohol dependence	0.000317	0.00173	CcSEcCtD
Erlotinib—CYP1B1—endocrine gland—alcohol dependence	0.000312	0.00231	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000308	0.00168	CcSEcCtD
Erlotinib—ALB—liver—alcohol dependence	0.000307	0.00227	CbGeAlD
Erlotinib—Insomnia—Citalopram—alcohol dependence	0.000306	0.00166	CcSEcCtD
Erlotinib—CYP3A5—pancreas—alcohol dependence	0.000306	0.00226	CbGeAlD
Erlotinib—Dyspnoea—Citalopram—alcohol dependence	0.000301	0.00164	CcSEcCtD
Erlotinib—Dyspepsia—Citalopram—alcohol dependence	0.000298	0.00162	CcSEcCtD
Erlotinib—CYP1B1—testis—alcohol dependence	0.000298	0.0022	CbGeAlD
Erlotinib—Decreased appetite—Citalopram—alcohol dependence	0.000294	0.0016	CcSEcCtD
Erlotinib—CYP1B1—nervous system—alcohol dependence	0.000292	0.00216	CbGeAlD
Erlotinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000292	0.00159	CcSEcCtD
Erlotinib—Fatigue—Citalopram—alcohol dependence	0.000292	0.00159	CcSEcCtD
Erlotinib—Pain—Citalopram—alcohol dependence	0.000289	0.00157	CcSEcCtD
Erlotinib—Constipation—Citalopram—alcohol dependence	0.000289	0.00157	CcSEcCtD
Erlotinib—CYP2D6—brainstem—alcohol dependence	0.000285	0.0021	CbGeAlD
Erlotinib—CYP1B1—liver—alcohol dependence	0.000281	0.00208	CbGeAlD
Erlotinib—CYP1B1—central nervous system—alcohol dependence	0.000281	0.00208	CbGeAlD
Erlotinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000277	0.00151	CcSEcCtD
Erlotinib—CYP2C8—blood—alcohol dependence	0.000276	0.00204	CbGeAlD
Erlotinib—CYP1B1—cerebellum—alcohol dependence	0.000275	0.00203	CbGeAlD
Erlotinib—CYP2D6—forebrain—alcohol dependence	0.000275	0.00203	CbGeAlD
Erlotinib—CYP1A2—digestive system—alcohol dependence	0.000271	0.002	CbGeAlD
Erlotinib—ABCG2—blood—alcohol dependence	0.000268	0.00198	CbGeAlD
Erlotinib—Body temperature increased—Citalopram—alcohol dependence	0.000267	0.00146	CcSEcCtD
Erlotinib—Abdominal pain—Citalopram—alcohol dependence	0.000267	0.00146	CcSEcCtD
Erlotinib—CYP1A1—digestive system—alcohol dependence	0.000267	0.00197	CbGeAlD
Erlotinib—SLCO2B1—brain—alcohol dependence	0.000266	0.00197	CbGeAlD
Erlotinib—ABCG2—midbrain—alcohol dependence	0.000265	0.00196	CbGeAlD
Erlotinib—ABL1—brain—alcohol dependence	0.000264	0.00195	CbGeAlD
Erlotinib—CYP3A5—digestive system—alcohol dependence	0.000261	0.00193	CbGeAlD
Erlotinib—CYP1A2—blood—alcohol dependence	0.000258	0.00191	CbGeAlD
Erlotinib—CYP1A1—blood—alcohol dependence	0.000254	0.00188	CbGeAlD
Erlotinib—CYP3A5—blood—alcohol dependence	0.000249	0.00184	CbGeAlD
Erlotinib—ALB—brain—alcohol dependence	0.000243	0.0018	CbGeAlD
Erlotinib—Asthenia—Citalopram—alcohol dependence	0.000243	0.00132	CcSEcCtD
Erlotinib—Pruritus—Citalopram—alcohol dependence	0.000239	0.0013	CcSEcCtD
Erlotinib—CYP2C8—endocrine gland—alcohol dependence	0.000239	0.00177	CbGeAlD
Erlotinib—Diarrhoea—Citalopram—alcohol dependence	0.000231	0.00126	CcSEcCtD
Erlotinib—CYP2C8—testis—alcohol dependence	0.000228	0.00168	CbGeAlD
Erlotinib—CYP1A2—endocrine gland—alcohol dependence	0.000224	0.00165	CbGeAlD
Erlotinib—Dizziness—Citalopram—alcohol dependence	0.000224	0.00122	CcSEcCtD
Erlotinib—CYP1B1—brain—alcohol dependence	0.000223	0.00165	CbGeAlD
Erlotinib—ABCG2—testis—alcohol dependence	0.000222	0.00164	CbGeAlD
Erlotinib—CYP1A1—endocrine gland—alcohol dependence	0.000221	0.00163	CbGeAlD
Erlotinib—CYP3A5—endocrine gland—alcohol dependence	0.000216	0.00159	CbGeAlD
Erlotinib—CYP2C8—liver—alcohol dependence	0.000216	0.00159	CbGeAlD
Erlotinib—Vomiting—Citalopram—alcohol dependence	0.000215	0.00117	CcSEcCtD
Erlotinib—Rash—Citalopram—alcohol dependence	0.000213	0.00116	CcSEcCtD
Erlotinib—Dermatitis—Citalopram—alcohol dependence	0.000213	0.00116	CcSEcCtD
Erlotinib—Headache—Citalopram—alcohol dependence	0.000212	0.00115	CcSEcCtD
Erlotinib—ABCG2—liver—alcohol dependence	0.00021	0.00155	CbGeAlD
Erlotinib—CYP1A1—nervous system—alcohol dependence	0.000207	0.00153	CbGeAlD
Erlotinib—ABCG2—cerebellum—alcohol dependence	0.000205	0.00151	CbGeAlD
Erlotinib—CYP1A2—liver—alcohol dependence	0.000202	0.00149	CbGeAlD
Erlotinib—Nausea—Citalopram—alcohol dependence	0.000201	0.00109	CcSEcCtD
Erlotinib—CYP1A1—liver—alcohol dependence	0.000199	0.00147	CbGeAlD
Erlotinib—CYP1A1—central nervous system—alcohol dependence	0.000199	0.00147	CbGeAlD
Erlotinib—ABCB1—forebrain—alcohol dependence	0.000198	0.00146	CbGeAlD
Erlotinib—CYP3A4—digestive system—alcohol dependence	0.000196	0.00145	CbGeAlD
Erlotinib—CYP3A5—liver—alcohol dependence	0.000195	0.00144	CbGeAlD
Erlotinib—CYP2D6—digestive system—alcohol dependence	0.000193	0.00143	CbGeAlD
Erlotinib—CYP3A4—blood—alcohol dependence	0.000187	0.00138	CbGeAlD
Erlotinib—CYP2D6—blood—alcohol dependence	0.000184	0.00136	CbGeAlD
Erlotinib—ABCB1—adrenal cortex—alcohol dependence	0.000183	0.00135	CbGeAlD
Erlotinib—CYP2C8—brain—alcohol dependence	0.000171	0.00126	CbGeAlD
Erlotinib—ABCB1—cardiovascular system—alcohol dependence	0.000167	0.00123	CbGeAlD
Erlotinib—ABCG2—brain—alcohol dependence	0.000166	0.00123	CbGeAlD
Erlotinib—ABCB1—pancreas—alcohol dependence	0.000162	0.0012	CbGeAlD
Erlotinib—CYP3A4—endocrine gland—alcohol dependence	0.000162	0.0012	CbGeAlD
Erlotinib—CYP2D6—endocrine gland—alcohol dependence	0.000159	0.00118	CbGeAlD
Erlotinib—CYP1A1—brain—alcohol dependence	0.000158	0.00117	CbGeAlD
Erlotinib—CYP2D6—testis—alcohol dependence	0.000152	0.00112	CbGeAlD
Erlotinib—ABCB1—gonad—alcohol dependence	0.000152	0.00112	CbGeAlD
Erlotinib—CYP3A4—nervous system—alcohol dependence	0.000152	0.00112	CbGeAlD
Erlotinib—CYP2D6—nervous system—alcohol dependence	0.000149	0.0011	CbGeAlD
Erlotinib—CYP3A4—liver—alcohol dependence	0.000146	0.00108	CbGeAlD
Erlotinib—CYP3A4—central nervous system—alcohol dependence	0.000146	0.00108	CbGeAlD
Erlotinib—CYP2D6—liver—alcohol dependence	0.000144	0.00106	CbGeAlD
Erlotinib—CYP2D6—central nervous system—alcohol dependence	0.000144	0.00106	CbGeAlD
Erlotinib—CYP2D6—cerebellum—alcohol dependence	0.00014	0.00104	CbGeAlD
Erlotinib—ABCB1—digestive system—alcohol dependence	0.000139	0.00103	CbGeAlD
Erlotinib—ABCB1—blood—alcohol dependence	0.000132	0.000977	CbGeAlD
Erlotinib—ABCB1—midbrain—alcohol dependence	0.00013	0.000964	CbGeAlD
Erlotinib—ABCB1—endocrine gland—alcohol dependence	0.000115	0.000847	CbGeAlD
Erlotinib—CYP2D6—brain—alcohol dependence	0.000114	0.000842	CbGeAlD
Erlotinib—ABCB1—testis—alcohol dependence	0.000109	0.000808	CbGeAlD
Erlotinib—ABCB1—nervous system—alcohol dependence	0.000107	0.000793	CbGeAlD
Erlotinib—ABCB1—liver—alcohol dependence	0.000103	0.000764	CbGeAlD
Erlotinib—ABCB1—central nervous system—alcohol dependence	0.000103	0.000763	CbGeAlD
Erlotinib—ABCB1—cerebellum—alcohol dependence	0.000101	0.000746	CbGeAlD
Erlotinib—ABCB1—brain—alcohol dependence	8.2e-05	0.000606	CbGeAlD
Erlotinib—ALB—Metabolism—ADH6—alcohol dependence	4.07e-05	0.000341	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.06e-05	0.00034	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—MAOA—alcohol dependence	4.05e-05	0.000339	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	3.99e-05	0.000334	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—POMC—alcohol dependence	3.99e-05	0.000334	CbGpPWpGaD
Erlotinib—EGFR—Immune System—WASF1—alcohol dependence	3.98e-05	0.000333	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NPY—alcohol dependence	3.97e-05	0.000332	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ADH7—alcohol dependence	3.95e-05	0.000331	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—EP300—alcohol dependence	3.92e-05	0.000328	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CNR1—alcohol dependence	3.92e-05	0.000328	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—OPRM1—alcohol dependence	3.92e-05	0.000328	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADH1A—alcohol dependence	3.92e-05	0.000328	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	3.88e-05	0.000325	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	3.84e-05	0.000321	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.83e-05	0.000321	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CRH—alcohol dependence	3.83e-05	0.000321	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR1B—alcohol dependence	3.83e-05	0.000321	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR7—alcohol dependence	3.83e-05	0.00032	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—DRD2—alcohol dependence	3.83e-05	0.00032	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ADH1B—alcohol dependence	3.81e-05	0.000319	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	3.8e-05	0.000318	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—POMC—alcohol dependence	3.79e-05	0.000317	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GGT2—alcohol dependence	3.79e-05	0.000317	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	3.75e-05	0.000314	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADH1A—alcohol dependence	3.7e-05	0.00031	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—POMC—alcohol dependence	3.62e-05	0.000303	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—NPY—alcohol dependence	3.61e-05	0.000302	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADH6—alcohol dependence	3.57e-05	0.000298	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2A—alcohol dependence	3.55e-05	0.000297	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	3.49e-05	0.000292	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR1B—alcohol dependence	3.48e-05	0.000291	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CRH—alcohol dependence	3.48e-05	0.000291	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ADH1B—alcohol dependence	3.46e-05	0.00029	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADH1A—alcohol dependence	3.39e-05	0.000284	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MAOB—alcohol dependence	3.38e-05	0.000283	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADH1A—alcohol dependence	3.37e-05	0.000282	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADH6—alcohol dependence	3.36e-05	0.000281	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	3.36e-05	0.000281	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—DRD4—alcohol dependence	3.35e-05	0.00028	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADH4—alcohol dependence	3.33e-05	0.000279	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AVP—alcohol dependence	3.22e-05	0.00027	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CNR1—alcohol dependence	3.2e-05	0.000268	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MAOB—alcohol dependence	3.16e-05	0.000264	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADH4—alcohol dependence	3.15e-05	0.000263	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	3.13e-05	0.000262	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR7—alcohol dependence	3.12e-05	0.000261	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—DRD2—alcohol dependence	3.12e-05	0.000261	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—POMC—alcohol dependence	3.11e-05	0.000261	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—DRD4—alcohol dependence	3.04e-05	0.000255	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—OPRD1—alcohol dependence	3.01e-05	0.000252	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADH1A—alcohol dependence	2.95e-05	0.000247	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CNR1—alcohol dependence	2.9e-05	0.000243	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PDYN—alcohol dependence	2.88e-05	0.000241	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADH4—alcohol dependence	2.88e-05	0.000241	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALDH2—alcohol dependence	2.88e-05	0.000241	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MAOB—alcohol dependence	2.87e-05	0.00024	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADH4—alcohol dependence	2.87e-05	0.00024	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADH6—alcohol dependence	2.85e-05	0.000238	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—POMC—alcohol dependence	2.84e-05	0.000238	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—DRD2—alcohol dependence	2.83e-05	0.000237	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR7—alcohol dependence	2.83e-05	0.000237	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADH7—alcohol dependence	2.83e-05	0.000237	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.78e-05	0.000233	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.72e-05	0.000228	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GGT2—alcohol dependence	2.71e-05	0.000227	CbGpPWpGaD
Erlotinib—MKNK1—Disease—EP300—alcohol dependence	2.69e-05	0.000225	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALDH2—alcohol dependence	2.68e-05	0.000225	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—WASF2—alcohol dependence	2.68e-05	0.000224	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CRHR1—alcohol dependence	2.68e-05	0.000224	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2A—alcohol dependence	2.68e-05	0.000224	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADH7—alcohol dependence	2.67e-05	0.000224	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT2—alcohol dependence	2.65e-05	0.000222	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	2.65e-05	0.000221	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—POMC—alcohol dependence	2.64e-05	0.000221	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AVP—alcohol dependence	2.63e-05	0.00022	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.58e-05	0.000216	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—WASF1—alcohol dependence	2.57e-05	0.000215	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT2—alcohol dependence	2.56e-05	0.000215	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CHRM2—alcohol dependence	2.52e-05	0.000211	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADH4—alcohol dependence	2.51e-05	0.00021	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.51e-05	0.00021	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.5e-05	0.000209	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.48e-05	0.000208	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ADH1B—alcohol dependence	2.48e-05	0.000208	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADH7—alcohol dependence	2.45e-05	0.000205	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT2—alcohol dependence	2.45e-05	0.000205	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALDH2—alcohol dependence	2.44e-05	0.000204	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADH7—alcohol dependence	2.44e-05	0.000204	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AVP—alcohol dependence	2.39e-05	0.0002	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADH4—alcohol dependence	2.37e-05	0.000198	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADH1A—alcohol dependence	2.36e-05	0.000197	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT2—alcohol dependence	2.35e-05	0.000197	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ADH1B—alcohol dependence	2.35e-05	0.000196	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT2—alcohol dependence	2.34e-05	0.000196	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—OPRM1—alcohol dependence	2.32e-05	0.000194	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CYP2E1—alcohol dependence	2.3e-05	0.000192	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT1—alcohol dependence	2.29e-05	0.000192	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT2—alcohol dependence	2.28e-05	0.000191	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.2e-05	0.000184	CbGpPWpGaD
Erlotinib—JAK3—Immune System—EP300—alcohol dependence	2.2e-05	0.000184	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.2e-05	0.000184	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—EP300—alcohol dependence	2.19e-05	0.000183	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	2.18e-05	0.000183	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ADH1B—alcohol dependence	2.15e-05	0.00018	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CYP2E1—alcohol dependence	2.15e-05	0.00018	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—EP300—alcohol dependence	2.14e-05	0.000179	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—POMC—alcohol dependence	2.14e-05	0.000179	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ADH1B—alcohol dependence	2.14e-05	0.000179	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADH7—alcohol dependence	2.14e-05	0.000179	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NPY—alcohol dependence	2.13e-05	0.000178	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GGT1—alcohol dependence	2.11e-05	0.000177	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT1—alcohol dependence	2.11e-05	0.000177	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT2—alcohol dependence	2.08e-05	0.000174	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	2.07e-05	0.000173	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MAOB—alcohol dependence	2.06e-05	0.000172	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1B—alcohol dependence	2.06e-05	0.000172	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CRH—alcohol dependence	2.06e-05	0.000172	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT2—alcohol dependence	2.05e-05	0.000171	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.04e-05	0.00017	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.02e-05	0.000169	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADH7—alcohol dependence	2.01e-05	0.000168	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADH4—alcohol dependence	2.01e-05	0.000168	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2A—alcohol dependence	1.98e-05	0.000166	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GGT1—alcohol dependence	1.97e-05	0.000165	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT1—alcohol dependence	1.97e-05	0.000165	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.95e-05	0.000163	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MAOB—alcohol dependence	1.94e-05	0.000163	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—EP300—alcohol dependence	1.93e-05	0.000162	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT2—alcohol dependence	1.93e-05	0.000162	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MAOA—alcohol dependence	1.89e-05	0.000158	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—EP300—alcohol dependence	1.88e-05	0.000158	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.87e-05	0.000157	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—EP300—alcohol dependence	1.87e-05	0.000156	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.82e-05	0.000152	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.82e-05	0.000152	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD4—alcohol dependence	1.8e-05	0.00015	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT1—alcohol dependence	1.79e-05	0.00015	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GGT1—alcohol dependence	1.79e-05	0.00015	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MAOB—alcohol dependence	1.78e-05	0.000149	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MAOB—alcohol dependence	1.77e-05	0.000148	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.77e-05	0.000148	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MAOA—alcohol dependence	1.76e-05	0.000148	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	1.75e-05	0.000146	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	1.74e-05	0.000146	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.74e-05	0.000145	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CNR1—alcohol dependence	1.72e-05	0.000144	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.71e-05	0.000143	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADH7—alcohol dependence	1.71e-05	0.000143	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—DRD2—alcohol dependence	1.67e-05	0.00014	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR7—alcohol dependence	1.67e-05	0.00014	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALDH2—alcohol dependence	1.65e-05	0.000138	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—EP300—alcohol dependence	1.65e-05	0.000138	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT2—alcohol dependence	1.64e-05	0.000137	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MAOA—alcohol dependence	1.61e-05	0.000134	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.59e-05	0.000133	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—POMC—alcohol dependence	1.58e-05	0.000133	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MAOB—alcohol dependence	1.55e-05	0.00013	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.55e-05	0.00013	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALDH2—alcohol dependence	1.51e-05	0.000127	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ALDH2—alcohol dependence	1.51e-05	0.000126	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ADH1B—alcohol dependence	1.5e-05	0.000125	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT2—alcohol dependence	1.49e-05	0.000124	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOB—alcohol dependence	1.46e-05	0.000122	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.46e-05	0.000122	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.45e-05	0.000121	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—EP300—alcohol dependence	1.42e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AVP—alcohol dependence	1.41e-05	0.000118	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT2—alcohol dependence	1.41e-05	0.000118	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.4e-05	0.000117	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP2E1—alcohol dependence	1.32e-05	0.000111	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.32e-05	0.00011	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.32e-05	0.00011	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT2—alcohol dependence	1.29e-05	0.000108	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT1—alcohol dependence	1.28e-05	0.000107	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GGT1—alcohol dependence	1.28e-05	0.000107	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT2—alcohol dependence	1.28e-05	0.000107	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.26e-05	0.000106	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.24e-05	0.000104	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOB—alcohol dependence	1.24e-05	0.000104	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—alcohol dependence	1.23e-05	0.000103	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT1—alcohol dependence	1.21e-05	0.000101	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT1—alcohol dependence	1.21e-05	0.000101	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.21e-05	0.000101	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP2E1—alcohol dependence	1.2e-05	0.000101	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—alcohol dependence	1.17e-05	9.81e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	1.16e-05	9.69e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.15e-05	9.66e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MAOA—alcohol dependence	1.15e-05	9.63e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—alcohol dependence	1.15e-05	9.62e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—EP300—alcohol dependence	1.12e-05	9.41e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT2—alcohol dependence	1.12e-05	9.39e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT1—alcohol dependence	1.11e-05	9.3e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT1—alcohol dependence	1.11e-05	9.3e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT1—alcohol dependence	1.11e-05	9.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT1—alcohol dependence	1.11e-05	9.25e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MAOA—alcohol dependence	1.09e-05	9.1e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT2—alcohol dependence	1.06e-05	8.85e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—EP300—alcohol dependence	1.06e-05	8.83e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.06e-05	8.83e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.05e-05	8.82e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.05e-05	8.82e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—alcohol dependence	1.05e-05	8.75e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.01e-05	8.48e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MAOA—alcohol dependence	9.96e-06	8.34e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.94e-06	8.32e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MAOA—alcohol dependence	9.91e-06	8.29e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT1—alcohol dependence	9.69e-06	8.11e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT1—alcohol dependence	9.69e-06	8.11e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.66e-06	8.09e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.61e-06	8.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—EP300—alcohol dependence	9.61e-06	8.04e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOB—alcohol dependence	9.56e-06	8e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—alcohol dependence	9.36e-06	7.84e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT1—alcohol dependence	9.13e-06	7.64e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT1—alcohol dependence	9.13e-06	7.64e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT2—alcohol dependence	8.96e-06	7.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—EP300—alcohol dependence	8.87e-06	7.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MAOA—alcohol dependence	8.68e-06	7.26e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2E1—alcohol dependence	8.42e-06	7.05e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOA—alcohol dependence	8.18e-06	6.85e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—EP300—alcohol dependence	8.17e-06	6.84e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	8.13e-06	6.8e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—alcohol dependence	7.73e-06	6.47e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—alcohol dependence	7.73e-06	6.47e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—EP300—alcohol dependence	7.62e-06	6.38e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—alcohol dependence	7.49e-06	6.27e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—alcohol dependence	7.08e-06	5.92e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—EP300—alcohol dependence	6.93e-06	5.8e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOA—alcohol dependence	6.93e-06	5.8e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—alcohol dependence	6.91e-06	5.79e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.72e-06	5.62e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.5e-06	5.44e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—alcohol dependence	6.49e-06	5.43e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—alcohol dependence	6.45e-06	5.4e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EP300—alcohol dependence	6.21e-06	5.2e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—alcohol dependence	5.97e-06	4.99e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—alcohol dependence	5.97e-06	4.99e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—alcohol dependence	5.65e-06	4.73e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOA—alcohol dependence	5.35e-06	4.48e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—alcohol dependence	5.33e-06	4.46e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—EP300—alcohol dependence	4.97e-06	4.16e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—EP300—alcohol dependence	4.69e-06	3.93e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—alcohol dependence	4.51e-06	3.78e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—EP300—alcohol dependence	4.3e-06	3.6e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—EP300—alcohol dependence	4.28e-06	3.58e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—EP300—alcohol dependence	3.75e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—EP300—alcohol dependence	3.53e-06	2.96e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—alcohol dependence	3.48e-06	2.91e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—EP300—alcohol dependence	2.99e-06	2.5e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—EP300—alcohol dependence	2.31e-06	1.93e-05	CbGpPWpGaD
